10-Q Filing

TEVA PHARMACEUTICAL INDUSTRIES LTD CIK: 818686 Q1 2025

Filing Information

Form Type	10-Q
Accession Number	`0001193125-25-114889`
Period End Date	20250331
Filing Date	20250507
Fiscal Year	2025
Fiscal Period	Q1
XBRL Instance	d907688d10q_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 180 Income Statement 88 Cash Flow Statement 104 Stockholders Equity 48 Comprehensive Income 32

Balance Sheet 180 line items

Line Item	Tag	Value	Unit	Period
Allowance for credit losses	`AllowanceForDoubtfulAccountsReceivableCurrent`	$78.00M	USD	Point-in-time
Allowance for credit losses	`AllowanceForDoubtfulAccountsReceivableCurrent`	$78.00M	USD	Point-in-time
Allowance for credit losses	`AllowanceForDoubtfulAccountsReceivableCurrent`	$80.00M	USD	Point-in-time
Allowance for credit losses	`AllowanceForDoubtfulAccountsReceivableCurrent`	$80.00M	USD	Point-in-time
Common stock, par or stated value per share	`CommonStockParOrStatedValuePerShare`	0.10	ILS	Point-in-time
Common stock, par or stated value per share	`CommonStockParOrStatedValuePerShare`	0.10	ILS	Point-in-time
Common stock, par or stated value per share	`CommonStockParOrStatedValuePerShare`	0.10	ILS	Point-in-time
Common stock, par or stated value per share	`CommonStockParOrStatedValuePerShare`	0.10	ILS	Point-in-time
Ordinary shares, authorized	`CommonStockSharesAuthorized`	2.50B	shares	Point-in-time
Ordinary shares, authorized	`CommonStockSharesAuthorized`	2.50B	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$3.30B	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$3.30B	USD	Point-in-time
Ordinary shares, authorized	`CommonStockSharesAuthorized`	2.50B	shares	Point-in-time
Ordinary shares, authorized	`CommonStockSharesAuthorized`	2.50B	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$1.70B	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$1.70B	USD	Point-in-time
Ordinary shares, issued	`CommonStockSharesIssued`	1.24B	shares	Point-in-time
Ordinary shares, issued	`CommonStockSharesIssued`	1.24B	shares	Point-in-time
Ordinary shares, issued	`CommonStockSharesIssued`	1.25B	shares	Point-in-time
Ordinary shares, issued	`CommonStockSharesIssued`	1.25B	shares	Point-in-time
Accounts receivables, net of allowance for credit losses of $80 million and $78 million as of March 31, 2025 and December 31, 2024, respectively	`AccountsReceivableNetCurrent`	$3.06B	USD	Point-in-time
Accounts receivables, net of allowance for credit losses of $80 million and $78 million as of March 31, 2025 and December 31, 2024, respectively	`AccountsReceivableNetCurrent`	$3.06B	USD	Point-in-time
Accounts receivables, net of allowance for credit losses of $80 million and $78 million as of March 31, 2025 and December 31, 2024, respectively	`AccountsReceivableNetCurrent`	$3.38B	USD	Point-in-time
Accounts receivables, net of allowance for credit losses of $80 million and $78 million as of March 31, 2025 and December 31, 2024, respectively	`AccountsReceivableNetCurrent`	$3.38B	USD	Point-in-time
Inventories	`InventoryNet`	$3.01B	USD	Point-in-time
Inventories	`InventoryNet`	$3.01B	USD	Point-in-time
Treasury shares	`TreasuryStockCommonShares`	106.00M	shares	Point-in-time
Treasury shares	`TreasuryStockCommonShares`	106.00M	shares	Point-in-time
Treasury shares	`TreasuryStockCommonShares`	106.00M	shares	Point-in-time
Treasury shares	`TreasuryStockCommonShares`	106.00M	shares	Point-in-time
Inventories	`InventoryNet`	$3.25B	USD	Point-in-time
Inventories	`InventoryNet`	$3.25B	USD	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$1.01B	USD	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$1.01B	USD	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$1.02B	USD	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$1.02B	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$368.00M	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$368.00M	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$409.00M	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$409.00M	USD	Point-in-time
Assets held for sale	`AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent`	$1.81B	USD	Point-in-time
Assets held for sale	`AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent`	$1.81B	USD	Point-in-time
Assets held for sale	`AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent`	$1.77B	USD	Point-in-time
Assets held for sale	`AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent`	$1.77B	USD	Point-in-time
Total current assets	`AssetsCurrent`	$12.55B	USD	Point-in-time
Total current assets	`AssetsCurrent`	$12.55B	USD	Point-in-time
Total current assets	`AssetsCurrent`	$11.53B	USD	Point-in-time
Total current assets	`AssetsCurrent`	$11.53B	USD	Point-in-time
Deferred income taxes	`DeferredIncomeTaxAssetsNet`	$1.80B	USD	Point-in-time
Deferred income taxes	`DeferredIncomeTaxAssetsNet`	$1.80B	USD	Point-in-time
Deferred income taxes	`DeferredIncomeTaxAssetsNet`	$1.76B	USD	Point-in-time
Deferred income taxes	`DeferredIncomeTaxAssetsNet`	$1.76B	USD	Point-in-time
Other non-current assets	`OtherAssetsNoncurrent`	$462.00M	USD	Point-in-time
Other non-current assets	`OtherAssetsNoncurrent`	$462.00M	USD	Point-in-time
Other non-current assets	`OtherAssetsNoncurrent`	$464.00M	USD	Point-in-time
Other non-current assets	`OtherAssetsNoncurrent`	$464.00M	USD	Point-in-time
Property, plant and equipment, net	`PropertyPlantAndEquipmentNet`	$4.58B	USD	Point-in-time
Property, plant and equipment, net	`PropertyPlantAndEquipmentNet`	$4.58B	USD	Point-in-time
Property, plant and equipment, net	`PropertyPlantAndEquipmentNet`	$4.63B	USD	Point-in-time
Property, plant and equipment, net	`PropertyPlantAndEquipmentNet`	$4.63B	USD	Point-in-time
Operating lease right-of-use assets, net	`OperatingLeaseRightOfUseAsset`	$367.00M	USD	Point-in-time
Operating lease right-of-use assets, net	`OperatingLeaseRightOfUseAsset`	$367.00M	USD	Point-in-time
Operating lease right-of-use assets, net	`OperatingLeaseRightOfUseAsset`	$363.00M	USD	Point-in-time
Operating lease right-of-use assets, net	`OperatingLeaseRightOfUseAsset`	$363.00M	USD	Point-in-time
Identifiable intangible assets, net	`FiniteLivedIntangibleAssetsNet`	$4.42B	USD	Point-in-time
Identifiable intangible assets, net	`FiniteLivedIntangibleAssetsNet`	$4.42B	USD	Point-in-time
Identifiable intangible assets, net	`FiniteLivedIntangibleAssetsNet`	$4.19B	USD	Point-in-time
Identifiable intangible assets, net	`FiniteLivedIntangibleAssetsNet`	$4.19B	USD	Point-in-time
Goodwill	`Goodwill`	$15.15B	USD	Point-in-time
Goodwill	`Goodwill`	$15.15B	USD	Point-in-time
Goodwill	`Goodwill`	$15.48B	USD	Point-in-time
Goodwill	`Goodwill`	$15.48B	USD	Point-in-time
Total assets	`Assets`	$39.33B	USD	Point-in-time
Total assets	`Assets`	$39.33B	USD	Point-in-time
Total assets	`Assets`	$38.41B	USD	Point-in-time
Total assets	`Assets`	$38.41B	USD	Point-in-time
Short-term debt	`DebtCurrent`	$1.78B	USD	Point-in-time
Short-term debt	`DebtCurrent`	$1.78B	USD	Point-in-time
Short-term debt	`DebtCurrent`	$421.00M	USD	Point-in-time
Short-term debt	`DebtCurrent`	$421.00M	USD	Point-in-time
Sales reserves and allowances	`SalesReservesAndAllowances`	$3.68B	USD	Point-in-time
Sales reserves and allowances	`SalesReservesAndAllowances`	$3.68B	USD	Point-in-time
Sales reserves and allowances	`SalesReservesAndAllowances`	$3.70B	USD	Point-in-time
Sales reserves and allowances	`SalesReservesAndAllowances`	$3.70B	USD	Point-in-time
Accounts payables	`AccountsPayableTradeCurrent`	$2.20B	USD	Point-in-time
Accounts payables	`AccountsPayableTradeCurrent`	$2.20B	USD	Point-in-time
Accounts payables	`AccountsPayableTradeCurrent`	$2.29B	USD	Point-in-time
Accounts payables	`AccountsPayableTradeCurrent`	$2.29B	USD	Point-in-time
Employee-related obligations	`EmployeeRelatedLiabilitiesCurrent`	$474.00M	USD	Point-in-time
Employee-related obligations	`EmployeeRelatedLiabilitiesCurrent`	$474.00M	USD	Point-in-time
Employee-related obligations	`EmployeeRelatedLiabilitiesCurrent`	$624.00M	USD	Point-in-time
Employee-related obligations	`EmployeeRelatedLiabilitiesCurrent`	$624.00M	USD	Point-in-time
Accrued expenses	`AccruedExpenses`	$2.95B	USD	Point-in-time
Accrued expenses	`AccruedExpenses`	$2.95B	USD	Point-in-time
Accrued expenses	`AccruedExpenses`	$2.79B	USD	Point-in-time
Accrued expenses	`AccruedExpenses`	$2.79B	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	$1.02B	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	$1.02B	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	$964.00M	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	$964.00M	USD	Point-in-time
Liabilities held for sale	`LiabilitiesHeldForSaleCurrent`	$698.00M	USD	Point-in-time
Liabilities held for sale	`LiabilitiesHeldForSaleCurrent`	$698.00M	USD	Point-in-time
Liabilities held for sale	`LiabilitiesHeldForSaleCurrent`	$358.00M	USD	Point-in-time
Liabilities held for sale	`LiabilitiesHeldForSaleCurrent`	$358.00M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$11.16B	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$11.16B	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$12.80B	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$12.80B	USD	Point-in-time
Deferred income taxes	`DeferredTaxAndOtherLiabilitiesNoncurrent`	$483.00M	USD	Point-in-time
Deferred income taxes	`DeferredTaxAndOtherLiabilitiesNoncurrent`	$483.00M	USD	Point-in-time
Deferred income taxes	`DeferredTaxAndOtherLiabilitiesNoncurrent`	$461.00M	USD	Point-in-time
Deferred income taxes	`DeferredTaxAndOtherLiabilitiesNoncurrent`	$461.00M	USD	Point-in-time
Other taxes and long-term liabilities	`OtherLiabilitiesNoncurrent`	$4.03B	USD	Point-in-time
Other taxes and long-term liabilities	`OtherLiabilitiesNoncurrent`	$4.03B	USD	Point-in-time
Other taxes and long-term liabilities	`OtherLiabilitiesNoncurrent`	$4.01B	USD	Point-in-time
Other taxes and long-term liabilities	`OtherLiabilitiesNoncurrent`	$4.01B	USD	Point-in-time
Senior notes and loans	`LongTermNotesAndLoans`	$16.00B	USD	Point-in-time
Senior notes and loans	`LongTermNotesAndLoans`	$16.00B	USD	Point-in-time
Senior notes and loans	`LongTermNotesAndLoans`	$16.23B	USD	Point-in-time
Senior notes and loans	`LongTermNotesAndLoans`	$16.23B	USD	Point-in-time
Operating lease liabilities	`OperatingLeaseLiabilityNoncurrent`	$296.00M	USD	Point-in-time
Operating lease liabilities	`OperatingLeaseLiabilityNoncurrent`	$296.00M	USD	Point-in-time
Operating lease liabilities	`OperatingLeaseLiabilityNoncurrent`	$288.00M	USD	Point-in-time
Operating lease liabilities	`OperatingLeaseLiabilityNoncurrent`	$288.00M	USD	Point-in-time
Total long-term liabilities	`LiabilitiesNoncurrent`	$20.99B	USD	Point-in-time
Total long-term liabilities	`LiabilitiesNoncurrent`	$20.99B	USD	Point-in-time
Total long-term liabilities	`LiabilitiesNoncurrent`	$20.81B	USD	Point-in-time
Total long-term liabilities	`LiabilitiesNoncurrent`	$20.81B	USD	Point-in-time
Commitments and contingencies, see note 10	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies, see note 10	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies, see note 10	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies, see note 10	`CommitmentsAndContingencies`	-	USD	Point-in-time
Total liabilities	`Liabilities`	$32.15B	USD	Point-in-time
Total liabilities	`Liabilities`	$32.15B	USD	Point-in-time
Total liabilities	`Liabilities`	$33.61B	USD	Point-in-time
Total liabilities	`Liabilities`	$33.61B	USD	Point-in-time
Redeemable non-controlling interests	`RedeemableNoncontrollingInterestEquityCarryingAmount`	$340.00M	USD	Point-in-time
Redeemable non-controlling interests	`RedeemableNoncontrollingInterestEquityCarryingAmount`	$340.00M	USD	Point-in-time
Redeemable non-controlling interests	`RedeemableNoncontrollingInterestEquityCarryingAmount`	-	USD	Point-in-time
Redeemable non-controlling interests	`RedeemableNoncontrollingInterestEquityCarryingAmount`	-	USD	Point-in-time
Ordinary shares of NIS 0.10 par value per share; March 31, 2025 and December 31, 2024: authorized 2,495 million shares; issued 1,253 million shares and 1,240 million shares, respectively.	`CommonStockValue`	$58.00M	USD	Point-in-time
Ordinary shares of NIS 0.10 par value per share; March 31, 2025 and December 31, 2024: authorized 2,495 million shares; issued 1,253 million shares and 1,240 million shares, respectively.	`CommonStockValue`	$58.00M	USD	Point-in-time
Ordinary shares of NIS 0.10 par value per share; March 31, 2025 and December 31, 2024: authorized 2,495 million shares; issued 1,253 million shares and 1,240 million shares, respectively.	`CommonStockValue`	$58.00M	USD	Point-in-time
Ordinary shares of NIS 0.10 par value per share; March 31, 2025 and December 31, 2024: authorized 2,495 million shares; issued 1,253 million shares and 1,240 million shares, respectively.	`CommonStockValue`	$58.00M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$27.96B	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$27.96B	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$27.76B	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$27.76B	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-14.96B	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-14.96B	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-15.17B	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-15.17B	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-2.67B	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-2.67B	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-3.15B	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-3.15B	USD	Point-in-time
Treasury shares as of March 31, 2025 and December 31, 2024: 106 million ordinary shares	`TreasuryStockValue`	$4.13B	USD	Point-in-time
Treasury shares as of March 31, 2025 and December 31, 2024: 106 million ordinary shares	`TreasuryStockValue`	$4.13B	USD	Point-in-time
Treasury shares as of March 31, 2025 and December 31, 2024: 106 million ordinary shares	`TreasuryStockValue`	$4.13B	USD	Point-in-time
Treasury shares as of March 31, 2025 and December 31, 2024: 106 million ordinary shares	`TreasuryStockValue`	$4.13B	USD	Point-in-time
Stockholders' equity attributable to Teva shareholders	`StockholdersEquity`	$6.26B	USD	Point-in-time
Stockholders' equity attributable to Teva shareholders	`StockholdersEquity`	$6.26B	USD	Point-in-time
Stockholders' equity attributable to Teva shareholders	`StockholdersEquity`	$5.37B	USD	Point-in-time
Stockholders' equity attributable to Teva shareholders	`StockholdersEquity`	$5.37B	USD	Point-in-time
Non-controlling interests	`MinorityInterest`	$7.00M	USD	Point-in-time
Non-controlling interests	`MinorityInterest`	$7.00M	USD	Point-in-time
Non-controlling interests	`MinorityInterest`	$7.00M	USD	Point-in-time
Non-controlling interests	`MinorityInterest`	$7.00M	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$8.13B	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$8.13B	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$5.38B	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$5.38B	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$6.27B	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$6.27B	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$7.54B	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$7.54B	USD	Point-in-time
Total liabilities, redeemable non-controlling interests and equity	`LiabilitiesAndStockholdersEquity`	$38.41B	USD	Point-in-time
Total liabilities, redeemable non-controlling interests and equity	`LiabilitiesAndStockholdersEquity`	$38.41B	USD	Point-in-time
Total liabilities, redeemable non-controlling interests and equity	`LiabilitiesAndStockholdersEquity`	$39.33B	USD	Point-in-time
Total liabilities, redeemable non-controlling interests and equity	`LiabilitiesAndStockholdersEquity`	$39.33B	USD	Point-in-time

Income Statement 88 line items

Line Item	Tag	Value	Unit	Period
Net revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$3.82B	USD	1 Quarter
Net revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$3.82B	USD	1 Quarter
Net revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$3.89B	USD	1 Quarter
Net revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$3.89B	USD	1 Quarter
Cost of sales	`CostOfGoodsAndServicesSold`	$2.05B	USD	1 Quarter
Cost of sales	`CostOfGoodsAndServicesSold`	$2.05B	USD	1 Quarter
Cost of sales	`CostOfGoodsAndServicesSold`	$2.01B	USD	1 Quarter
Cost of sales	`CostOfGoodsAndServicesSold`	$2.01B	USD	1 Quarter
Gross profit	`GrossProfit`	$1.77B	USD	1 Quarter
Gross profit	`GrossProfit`	$1.77B	USD	1 Quarter
Gross profit	`GrossProfit`	$1.88B	USD	1 Quarter
Gross profit	`GrossProfit`	$1.88B	USD	1 Quarter
Research and development expenses	`ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost`	$242.00M	USD	1 Quarter
Research and development expenses	`ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost`	$242.00M	USD	1 Quarter
Research and development expenses	`ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost`	$247.00M	USD	1 Quarter
Research and development expenses	`ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost`	$247.00M	USD	1 Quarter
Selling and marketing expenses	`SellingAndMarketingExpense`	$608.00M	USD	1 Quarter
Selling and marketing expenses	`SellingAndMarketingExpense`	$608.00M	USD	1 Quarter
Selling and marketing expenses	`SellingAndMarketingExpense`	$622.00M	USD	1 Quarter
Selling and marketing expenses	`SellingAndMarketingExpense`	$622.00M	USD	1 Quarter
General and administrative expenses	`GeneralAndAdministrativeExpense`	$297.00M	USD	1 Quarter
General and administrative expenses	`GeneralAndAdministrativeExpense`	$297.00M	USD	1 Quarter
General and administrative expenses	`GeneralAndAdministrativeExpense`	$278.00M	USD	1 Quarter
General and administrative expenses	`GeneralAndAdministrativeExpense`	$278.00M	USD	1 Quarter
Share in (profits) losses of associated companies net	`IncomeLossFromEquityMethodInvestments`	$-4.00M	USD	1 Quarter
Share in (profits) losses of associated companies net	`IncomeLossFromEquityMethodInvestments`	$-4.00M	USD	1 Quarter
Intangible assets impairments	`IntangibleAssetsImpairments`	$121.00M	USD	1 Quarter
Intangible assets impairments	`IntangibleAssetsImpairments`	$121.00M	USD	1 Quarter
Intangible assets impairments	`IntangibleAssetsImpairments`	$80.00M	USD	1 Quarter
Intangible assets impairments	`IntangibleAssetsImpairments`	$80.00M	USD	1 Quarter
Other assets impairments, restructuring and other items	`ImpairmentsRestructuringAndOthers`	$673.00M	USD	1 Quarter
Other assets impairments, restructuring and other items	`ImpairmentsRestructuringAndOthers`	$673.00M	USD	1 Quarter
Other assets impairments, restructuring and other items	`ImpairmentsRestructuringAndOthers`	$-22.00M	USD	1 Quarter
Other assets impairments, restructuring and other items	`ImpairmentsRestructuringAndOthers`	$-22.00M	USD	1 Quarter
Legal settlements and loss contingencies	`LegalSettlementsAndLossContingencies`	$106.00M	USD	1 Quarter
Legal settlements and loss contingencies	`LegalSettlementsAndLossContingencies`	$106.00M	USD	1 Quarter
Legal settlements and loss contingencies	`LegalSettlementsAndLossContingencies`	$86.00M	USD	1 Quarter
Legal settlements and loss contingencies	`LegalSettlementsAndLossContingencies`	$86.00M	USD	1 Quarter
Other loss (income)	`OtherOperatingIncomeExpenseNet`	$-5.00M	USD	1 Quarter
Other loss (income)	`OtherOperatingIncomeExpenseNet`	$-5.00M	USD	1 Quarter
Other loss (income)	`OtherOperatingIncomeExpenseNet`	$-1.00M	USD	1 Quarter
Other loss (income)	`OtherOperatingIncomeExpenseNet`	$-1.00M	USD	1 Quarter
Operating income (loss)	`OperatingIncomeLoss`	$-218.00M	USD	1 Quarter
Operating income (loss)	`OperatingIncomeLoss`	$-218.00M	USD	1 Quarter
Operating income (loss)	`OperatingIncomeLoss`	$519.00M	USD	1 Quarter
Operating income (loss)	`OperatingIncomeLoss`	$519.00M	USD	1 Quarter
Financial expenses, net	`NonoperatingIncomeExpense`	$-250.00M	USD	1 Quarter
Financial expenses, net	`NonoperatingIncomeExpense`	$-250.00M	USD	1 Quarter
Financial expenses, net	`NonoperatingIncomeExpense`	$-225.00M	USD	1 Quarter
Financial expenses, net	`NonoperatingIncomeExpense`	$-225.00M	USD	1 Quarter
Income (loss) before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-467.00M	USD	1 Quarter
Income (loss) before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-467.00M	USD	1 Quarter
Income (loss) before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$294.00M	USD	1 Quarter
Income (loss) before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$294.00M	USD	1 Quarter
Income taxes (benefit)	`IncomeTaxExpenseBenefit`	$-52.00M	USD	1 Quarter
Income taxes (benefit)	`IncomeTaxExpenseBenefit`	$-52.00M	USD	1 Quarter
Income taxes (benefit)	`IncomeTaxExpenseBenefit`	$74.00M	USD	1 Quarter
Income taxes (benefit)	`IncomeTaxExpenseBenefit`	$74.00M	USD	1 Quarter
Share in (profits) losses of associated companies, net	`IncomeLossFromEquityMethodInvestments`	$-4.00M	USD	1 Quarter
Share in (profits) losses of associated companies, net	`IncomeLossFromEquityMethodInvestments`	$-4.00M	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$-419.00M	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$-419.00M	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$220.00M	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$220.00M	USD	1 Quarter
Net income (loss) attributable to redeemable and non-redeemable non-controlling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$-280.00M	USD	1 Quarter
Net income (loss) attributable to redeemable and non-redeemable non-controlling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$-280.00M	USD	1 Quarter
Net income (loss) attributable to redeemable and non-redeemable non-controlling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$6.00M	USD	1 Quarter
Net income (loss) attributable to redeemable and non-redeemable non-controlling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$6.00M	USD	1 Quarter
Net income (loss) attributable to Teva	`NetIncomeLoss`	$214.00M	USD	1 Quarter
Net income (loss) attributable to Teva	`NetIncomeLoss`	$214.00M	USD	1 Quarter
Net income (loss) attributable to Teva	`NetIncomeLoss`	$-139.00M	USD	1 Quarter
Net income (loss) attributable to Teva	`NetIncomeLoss`	$-139.00M	USD	1 Quarter
Basic	`EarningsPerShareBasic`	$0.19	USD	1 Quarter
Basic	`EarningsPerShareBasic`	$0.19	USD	1 Quarter
Basic	`EarningsPerShareBasic`	$-0.12	USD	1 Quarter
Basic	`EarningsPerShareBasic`	$-0.12	USD	1 Quarter
Diluted	`EarningsPerShareDiluted`	$-0.12	USD	1 Quarter
Diluted	`EarningsPerShareDiluted`	$-0.12	USD	1 Quarter
Diluted	`EarningsPerShareDiluted`	$0.18	USD	1 Quarter
Diluted	`EarningsPerShareDiluted`	$0.18	USD	1 Quarter
Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	1.12B	shares	1 Quarter
Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	1.12B	shares	1 Quarter
Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	1.14B	shares	1 Quarter
Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	1.14B	shares	1 Quarter
Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	1.16B	shares	1 Quarter
Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	1.16B	shares	1 Quarter
Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	1.12B	shares	1 Quarter
Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	1.12B	shares	1 Quarter

Cash Flow Statement 104 line items

Line Item	Tag	Value	Unit	Period
Net income (loss)	`ProfitLoss`	$-419.00M	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$-419.00M	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$220.00M	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$220.00M	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$272.00M	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$272.00M	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$244.00M	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$244.00M	USD	1 Quarter
Impairment of long-lived assets and assets held for sale	`ImpairmentOfLongLivedAssetsAndAssetsHeldForSaleFiniteAndIndefiniteLivedIntangibleAssetsOtherThanGoodwill`	$77.00M	USD	1 Quarter
Impairment of long-lived assets and assets held for sale	`ImpairmentOfLongLivedAssetsAndAssetsHeldForSaleFiniteAndIndefiniteLivedIntangibleAssetsOtherThanGoodwill`	$77.00M	USD	1 Quarter
Impairment of long-lived assets and assets held for sale	`ImpairmentOfLongLivedAssetsAndAssetsHeldForSaleFiniteAndIndefiniteLivedIntangibleAssetsOtherThanGoodwill`	$679.00M	USD	1 Quarter
Impairment of long-lived assets and assets held for sale	`ImpairmentOfLongLivedAssetsAndAssetsHeldForSaleFiniteAndIndefiniteLivedIntangibleAssetsOtherThanGoodwill`	$679.00M	USD	1 Quarter
Net change in operating assets and liabilities	`IncreaseDecreaseInOperatingCapital`	$700.00M	USD	1 Quarter
Net change in operating assets and liabilities	`IncreaseDecreaseInOperatingCapital`	$700.00M	USD	1 Quarter
Net change in operating assets and liabilities	`IncreaseDecreaseInOperatingCapital`	$497.00M	USD	1 Quarter
Net change in operating assets and liabilities	`IncreaseDecreaseInOperatingCapital`	$497.00M	USD	1 Quarter
Deferred income taxes net and uncertain tax positions	`DeferredIncomeTaxesNetAndUncertainTaxPositions`	$28.00M	USD	1 Quarter
Deferred income taxes net and uncertain tax positions	`DeferredIncomeTaxesNetAndUncertainTaxPositions`	$28.00M	USD	1 Quarter
Deferred income taxes net and uncertain tax positions	`DeferredIncomeTaxesNetAndUncertainTaxPositions`	$-189.00M	USD	1 Quarter
Deferred income taxes net and uncertain tax positions	`DeferredIncomeTaxesNetAndUncertainTaxPositions`	$-189.00M	USD	1 Quarter
Stock-based compensation	`ShareBasedCompensation`	$34.00M	USD	1 Quarter
Stock-based compensation	`ShareBasedCompensation`	$34.00M	USD	1 Quarter
Stock-based compensation	`ShareBasedCompensation`	$28.00M	USD	1 Quarter
Stock-based compensation	`ShareBasedCompensation`	$28.00M	USD	1 Quarter
Other items	`OtherOperatingActivitiesCashFlowStatement`	$2.00M	USD	1 Quarter
Other items	`OtherOperatingActivitiesCashFlowStatement`	$2.00M	USD	1 Quarter
Other items	`OtherOperatingActivitiesCashFlowStatement`	$-8.00M	USD	1 Quarter
Other items	`OtherOperatingActivitiesCashFlowStatement`	$-8.00M	USD	1 Quarter
Net cash provided by (used in) operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-124.00M	USD	1 Quarter
Net cash provided by (used in) operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-124.00M	USD	1 Quarter
Net cash provided by (used in) operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-105.00M	USD	1 Quarter
Net cash provided by (used in) operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-105.00M	USD	1 Quarter
Beneficial interest collected in exchange for securitized trade receivables	`ProceedsFromBeneficialInterestInExchangeForSecuritizedAccountsReceivables`	$295.00M	USD	1 Quarter
Beneficial interest collected in exchange for securitized trade receivables	`ProceedsFromBeneficialInterestInExchangeForSecuritizedAccountsReceivables`	$295.00M	USD	1 Quarter
Beneficial interest collected in exchange for securitized trade receivables	`ProceedsFromBeneficialInterestInExchangeForSecuritizedAccountsReceivables`	$322.00M	USD	1 Quarter
Beneficial interest collected in exchange for securitized trade receivables	`ProceedsFromBeneficialInterestInExchangeForSecuritizedAccountsReceivables`	$322.00M	USD	1 Quarter
Purchases of property, plant and equipment and intangible assets	`PaymentsToAcquireProductiveAssets`	$127.00M	USD	1 Quarter
Purchases of property, plant and equipment and intangible assets	`PaymentsToAcquireProductiveAssets`	$127.00M	USD	1 Quarter
Purchases of property, plant and equipment and intangible assets	`PaymentsToAcquireProductiveAssets`	$124.00M	USD	1 Quarter
Purchases of property, plant and equipment and intangible assets	`PaymentsToAcquireProductiveAssets`	$124.00M	USD	1 Quarter
Proceeds from sale of business and long-lived assets, net	`ProceedsFromDivestitureOfBusinesses`	$17.00M	USD	1 Quarter
Proceeds from sale of business and long-lived assets, net	`ProceedsFromDivestitureOfBusinesses`	$17.00M	USD	1 Quarter
Proceeds from sale of business and long-lived assets, net	`ProceedsFromDivestitureOfBusinesses`	-	USD	1 Quarter
Proceeds from sale of business and long-lived assets, net	`ProceedsFromDivestitureOfBusinesses`	-	USD	1 Quarter
Acquisition of businesses, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	-	USD	1 Quarter
Acquisition of businesses, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	-	USD	1 Quarter
Acquisition of businesses, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$15.00M	USD	1 Quarter
Acquisition of businesses, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$15.00M	USD	1 Quarter
Purchases of investments and other assets	`PaymentToAcquireMarketableSecuritiesAndOtherAssets`	$11.00M	USD	1 Quarter
Purchases of investments and other assets	`PaymentToAcquireMarketableSecuritiesAndOtherAssets`	$11.00M	USD	1 Quarter
Purchases of investments and other assets	`PaymentToAcquireMarketableSecuritiesAndOtherAssets`	$12.00M	USD	1 Quarter
Purchases of investments and other assets	`PaymentToAcquireMarketableSecuritiesAndOtherAssets`	$12.00M	USD	1 Quarter
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$144.00M	USD	1 Quarter
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$144.00M	USD	1 Quarter
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$201.00M	USD	1 Quarter
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$201.00M	USD	1 Quarter
Repayment of senior notes and loans and other long term liabilities	`RepaymentsOfLongTermDebt`	$1.37B	USD	1 Quarter
Repayment of senior notes and loans and other long term liabilities	`RepaymentsOfLongTermDebt`	$1.37B	USD	1 Quarter
Repayment of senior notes and loans and other long term liabilities	`RepaymentsOfLongTermDebt`	-	USD	1 Quarter
Repayment of senior notes and loans and other long term liabilities	`RepaymentsOfLongTermDebt`	-	USD	1 Quarter
Purchase of shares from redeemable and non-redeemable non-controlling interests	`ProceedFromMinorityNonControllingShareholders`	$-64.00M	USD	1 Quarter
Purchase of shares from redeemable and non-redeemable non-controlling interests	`ProceedFromMinorityNonControllingShareholders`	$-64.00M	USD	1 Quarter
Purchase of shares from redeemable and non-redeemable non-controlling interests	`ProceedFromMinorityNonControllingShareholders`	$-38.00M	USD	1 Quarter
Purchase of shares from redeemable and non-redeemable non-controlling interests	`ProceedFromMinorityNonControllingShareholders`	$-38.00M	USD	1 Quarter
Dividends paid to redeemable and non-redeemable non-controlling interests	`DividendsPaidToNonControllingInterests`	$-340.00M	USD	1 Quarter
Dividends paid to redeemable and non-redeemable non-controlling interests	`DividendsPaidToNonControllingInterests`	$-340.00M	USD	1 Quarter
Dividends paid to redeemable and non-redeemable non-controlling interests	`DividendsPaidToNonControllingInterests`	$-78.00M	USD	1 Quarter
Dividends paid to redeemable and non-redeemable non-controlling interests	`DividendsPaidToNonControllingInterests`	$-78.00M	USD	1 Quarter
Other financing activities	`ProceedsFromPaymentsForOtherFinancingActivities`	$3.00M	USD	1 Quarter
Other financing activities	`ProceedsFromPaymentsForOtherFinancingActivities`	$3.00M	USD	1 Quarter
Other financing activities	`ProceedsFromPaymentsForOtherFinancingActivities`	$-9.00M	USD	1 Quarter
Other financing activities	`ProceedsFromPaymentsForOtherFinancingActivities`	$-9.00M	USD	1 Quarter
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-151.00M	USD	1 Quarter
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-151.00M	USD	1 Quarter
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-1.74B	USD	1 Quarter
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-1.74B	USD	1 Quarter
Translation adjustment on cash and cash equivalents	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$-104.00M	USD	1 Quarter
Translation adjustment on cash and cash equivalents	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$-104.00M	USD	1 Quarter
Translation adjustment on cash and cash equivalents	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$45.00M	USD	1 Quarter
Translation adjustment on cash and cash equivalents	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$45.00M	USD	1 Quarter
Net change in cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-236.00M	USD	1 Quarter
Net change in cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-236.00M	USD	1 Quarter
Net change in cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-1.60B	USD	1 Quarter
Net change in cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-1.60B	USD	1 Quarter
Balance of cash, cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$2.99B	USD	Point-in-time
Balance of cash, cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$2.99B	USD	Point-in-time
Balance of cash, cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$3.23B	USD	Point-in-time
Balance of cash, cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$3.23B	USD	Point-in-time
Balance of cash, cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$3.30B	USD	Point-in-time
Balance of cash, cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$3.30B	USD	Point-in-time
Balance of cash, cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$1.70B	USD	Point-in-time
Balance of cash, cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$1.70B	USD	Point-in-time
Balance of cash, cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$2.99B	USD	Point-in-time
Balance of cash, cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$2.99B	USD	Point-in-time
Balance of cash, cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$3.23B	USD	Point-in-time
Balance of cash, cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$3.23B	USD	Point-in-time
Balance of cash, cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$3.30B	USD	Point-in-time
Balance of cash, cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$3.30B	USD	Point-in-time
Balance of cash, cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$1.70B	USD	Point-in-time
Balance of cash, cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$1.70B	USD	Point-in-time
Beneficial interest obtained in exchange for securitized accounts receivables	`BeneficialInterestObtainedInExchangeForSecuritizedAccountsReceivables`	$312.00M	USD	1 Quarter
Beneficial interest obtained in exchange for securitized accounts receivables	`BeneficialInterestObtainedInExchangeForSecuritizedAccountsReceivables`	$312.00M	USD	1 Quarter
Beneficial interest obtained in exchange for securitized accounts receivables	`BeneficialInterestObtainedInExchangeForSecuritizedAccountsReceivables`	$311.00M	USD	1 Quarter
Beneficial interest obtained in exchange for securitized accounts receivables	`BeneficialInterestObtainedInExchangeForSecuritizedAccountsReceivables`	$311.00M	USD	1 Quarter

Stockholders Equity 48 line items

Line Item	Tag	Value	Unit	Period
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$8.13B	USD	Point-in-time
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$8.13B	USD	Point-in-time
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$5.38B	USD	Point-in-time
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$5.38B	USD	Point-in-time
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$6.27B	USD	Point-in-time
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$6.27B	USD	Point-in-time
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$7.54B	USD	Point-in-time
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$7.54B	USD	Point-in-time
Net income (loss)	`ProfitLoss`	$-419.00M	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$-419.00M	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$220.00M	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$220.00M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$214.00M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$214.00M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$-139.00M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$-139.00M	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$500.00M	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$500.00M	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$-117.00M	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$-117.00M	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$473.00M	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$473.00M	USD	1 Quarter
Issuance of Shares, value	`StockIssuedDuringPeriodValueNewIssues`	$1.00M	USD	1 Quarter
Issuance of Shares, value	`StockIssuedDuringPeriodValueNewIssues`	$1.00M	USD	1 Quarter
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$34.00M	USD	1 Quarter
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$34.00M	USD	1 Quarter
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$28.00M	USD	1 Quarter
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$28.00M	USD	1 Quarter
Proceeds from exercise of options	`ProceedsFromStockOptionsExercised`	$3.00M	USD	1 Quarter
Proceeds from exercise of options	`ProceedsFromStockOptionsExercised`	$3.00M	USD	1 Quarter
Proceeds from exercise of options	`ProceedsFromStockOptionsExercised`	$6.00M	USD	1 Quarter
Proceeds from exercise of options	`ProceedsFromStockOptionsExercised`	$6.00M	USD	1 Quarter
Dividend to non-controlling interests	`MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders`	$18.00M	USD	1 Quarter
Dividend to non-controlling interests	`MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders`	$18.00M	USD	1 Quarter
Purchase of shares from redeemable non-controlling interests	`MinorityInterestDecreaseFromRedemptions`	$64.00M	USD	1 Quarter
Purchase of shares from redeemable non-controlling interests	`MinorityInterestDecreaseFromRedemptions`	$64.00M	USD	1 Quarter
Purchase of shares from redeemable non-controlling interests	`MinorityInterestDecreaseFromRedemptions`	$38.00M	USD	1 Quarter
Purchase of shares from redeemable non-controlling interests	`MinorityInterestDecreaseFromRedemptions`	$38.00M	USD	1 Quarter
Purchase of shares from redeemable non-controlling interests	`NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance`	$165.00M	USD	1 Quarter
Purchase of shares from redeemable non-controlling interests	`NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance`	$165.00M	USD	1 Quarter
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$8.13B	USD	Point-in-time
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$8.13B	USD	Point-in-time
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$5.38B	USD	Point-in-time
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$5.38B	USD	Point-in-time
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$6.27B	USD	Point-in-time
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$6.27B	USD	Point-in-time
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$7.54B	USD	Point-in-time
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$7.54B	USD	Point-in-time

Comprehensive Income 32 line items

Line Item	Tag	Value	Unit	Period
Net income (loss)	`ProfitLoss`	$-419.00M	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$-419.00M	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$220.00M	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$220.00M	USD	1 Quarter
Currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$494.00M	USD	1 Quarter
Currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$494.00M	USD	1 Quarter
Currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-123.00M	USD	1 Quarter
Currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-123.00M	USD	1 Quarter
Unrealized gain (loss) from derivative financial instruments, net	`UnrealizedGainLossOnDerivativeNetOfTax`	$7.00M	USD	1 Quarter
Unrealized gain (loss) from derivative financial instruments, net	`UnrealizedGainLossOnDerivativeNetOfTax`	$7.00M	USD	1 Quarter
Unrealized gain (loss) from derivative financial instruments, net	`UnrealizedGainLossOnDerivativeNetOfTax`	$7.00M	USD	1 Quarter
Unrealized gain (loss) from derivative financial instruments, net	`UnrealizedGainLossOnDerivativeNetOfTax`	$7.00M	USD	1 Quarter
Unrealized loss on defined benefit plans	`OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax`	$-1.00M	USD	1 Quarter
Unrealized loss on defined benefit plans	`OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax`	$-1.00M	USD	1 Quarter
Unrealized loss on defined benefit plans	`OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax`	$-1.00M	USD	1 Quarter
Unrealized loss on defined benefit plans	`OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax`	$-1.00M	USD	1 Quarter
Total other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$500.00M	USD	1 Quarter
Total other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$500.00M	USD	1 Quarter
Total other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$-117.00M	USD	1 Quarter
Total other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$-117.00M	USD	1 Quarter
Total comprehensive income (loss)	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$-536.00M	USD	1 Quarter
Total comprehensive income (loss)	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$-536.00M	USD	1 Quarter
Total comprehensive income (loss)	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$720.00M	USD	1 Quarter
Total comprehensive income (loss)	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$720.00M	USD	1 Quarter
Comprehensive income (loss) attributable to redeemable and non-redeemable non-controlling interests	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$33.00M	USD	1 Quarter
Comprehensive income (loss) attributable to redeemable and non-redeemable non-controlling interests	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$33.00M	USD	1 Quarter
Comprehensive income (loss) attributable to redeemable and non-redeemable non-controlling interests	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$-322.00M	USD	1 Quarter
Comprehensive income (loss) attributable to redeemable and non-redeemable non-controlling interests	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$-322.00M	USD	1 Quarter
Comprehensive income (loss) attributable to Teva	`ComprehensiveIncomeNetOfTax`	$-214.00M	USD	1 Quarter
Comprehensive income (loss) attributable to Teva	`ComprehensiveIncomeNetOfTax`	$-214.00M	USD	1 Quarter
Comprehensive income (loss) attributable to Teva	`ComprehensiveIncomeNetOfTax`	$687.00M	USD	1 Quarter
Comprehensive income (loss) attributable to Teva	`ComprehensiveIncomeNetOfTax`	$687.00M	USD	1 Quarter

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.